| Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel U Creutzig, MM van Den Heuvel-Eibrink, B Gibson, MN Dworzak, ... Blood, The Journal of the American Society of Hematology 120 (16), 3187-3205, 2012 | 664 | 2012 |
| Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study BV Balgobind, SC Raimondi, J Harbott, M Zimmermann, TA Alonzo, ... Blood, The Journal of the American Society of Hematology 114 (12), 2489-2496, 2009 | 499 | 2009 |
| Clinical implications of FLT3 mutations in pediatric AML S Meshinchi, TA Alonzo, DL Stirewalt, M Zwaan, M Zimmerman, ... Blood 108 (12), 3654-3661, 2006 | 466 | 2006 |
| Collaborative efforts driving progress in pediatric acute myeloid leukemia CM Zwaan, EA Kolb, D Reinhardt, J Abrahamsson, S Adachi, R Aplenc, ... Journal of clinical oncology 33 (27), 2949, 2015 | 373 | 2015 |
| Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials U Creutzig, M Zimmermann, J Ritter, D Reinhardt, J Hermann, G Henze, ... Leukemia 19 (12), 2030-2042, 2005 | 330 | 2005 |
| NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern IHIM Hollink, MM van den Heuvel-Eibrink, ST Arentsen-Peters, ... Blood, The Journal of the American Society of Hematology 118 (13), 3645-3656, 2011 | 316 | 2011 |
| Next-generation personalised medicine for high-risk paediatric cancer patients–The INFORM pilot study BC Worst, CM van Tilburg, GP Balasubramanian, P Fiesel, R Witt, ... European journal of cancer 65, 91-101, 2016 | 309 | 2016 |
| Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98 U Creutzig, M Zimmermann, D Reinhardt, M Dworzak, J Stary, ... Journal of Clinical Oncology 22 (21), 4384-4393, 2004 | 306 | 2004 |
| Childhood cancer predisposition syndromes—a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology T Ripperger, SS Bielack, A Borkhardt, IB Brecht, B Burkhardt, ... American journal of medical genetics Part A 173 (4), 1017-1037, 2017 | 296 | 2017 |
| Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia BF Goemans, CHM Zwaan, M Miller, M Zimmermann, A Harlow, ... Leukemia 19 (9), 1536-1542, 2005 | 291 | 2005 |
| Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98 C Von Neuhoff, D Reinhardt, A Sander, M Zimmermann, J Bradtke, ... Journal of clinical oncology 28 (16), 2682-2689, 2010 | 290 | 2010 |
| FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance CM Zwaan, S Meshinchi, JP Radich, AJP Veerman, DR Huismans, ... Blood 102 (7), 2387-2394, 2003 | 287 | 2003 |
| The genetic basis and cell of origin of mixed phenotype acute leukaemia TB Alexander, Z Gu, I Iacobucci, K Dickerson, JK Choi, B Xu, ... Nature 562 (7727), 373-379, 2018 | 286 | 2018 |
| Treatment and prognostic impact of transient leukemia in neonates with Down syndrome JH Klusmann, U Creutzig, M Zimmermann, M Dworzak, N Jorch, ... Blood, The Journal of the American Society of Hematology 111 (6), 2991-2998, 2008 | 285 | 2008 |
| Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute … U Creutzig, J Ritter, M Zimmermann, D Reinhardt, J Hermann, F Berthold, ... Journal of Clinical Oncology 19 (10), 2705-2713, 2001 | 260 | 2001 |
| miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia JH Klusmann, Z Li, K Böhmer, A Maroz, ML Koch, S Emmrich, FJ Godinho, ... Genes & development 24 (5), 478-490, 2010 | 258 | 2010 |
| Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group GJL Kaspers, M Zimmermann, D Reinhardt, BES Gibson, RYJ Tamminga, ... Journal of Clinical Oncology 31 (5), 599-607, 2013 | 256 | 2013 |
| Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93 T Lehrnbecher, D Varwig, J Kaiser, D Reinhardt, T Klingebiel, U Creutzig Leukemia 18 (1), 72-77, 2004 | 255 | 2004 |
| AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity U Creutzig, D Reinhardt, S Diekamp, M Dworzak, J Stary, M Zimmermann Leukemia 19 (8), 1355-1360, 2005 | 238 | 2005 |
| Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004 U Creutzig, M Zimmermann, JP Bourquin, MN Dworzak, G Fleischhack, ... Blood, The Journal of the American Society of Hematology 122 (1), 37-43, 2013 | 216 | 2013 |
